Medical Ikkou Group Co.,Ltd. (TYO:3353)

Medical Ikkou Group Income Statement

Financials in millions JPY. Fiscal year is March - February.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2025	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Revenue	50,633	48,393	39,900	33,897	33,595	31,603
Revenue Growth (YoY)	19.53%	21.29%	17.71%	0.90%	6.30%	-1.37%
Cost of Revenue	44,693	42,649	35,349	30,715	29,982	28,401
Gross Profit	5,940	5,744	4,551	3,182	3,613	3,202
Selling, General & Admin	3,810	3,620	2,544	1,713	1,765	1,712
Other Operating Expenses	290	290	277	325	331	251
Operating Expenses	4,242	4,052	2,992	2,247	2,338	2,172
Operating Income	1,698	1,692	1,559	935	1,275	1,030
Interest Expense	-71	-63	-54	-50	-58	-53
Interest & Investment Income	73	72	47	39	30	27
Other Non Operating Income (Expenses)	180	114	198	301	110	199
EBT Excluding Unusual Items	1,880	1,815	1,750	1,225	1,357	1,203
Gain (Loss) on Sale of Investments	225	117	167	36	106	322
Gain (Loss) on Sale of Assets	7	77	-2	20	28	2
Asset Writedown	-243	-208	-256	-36	-10	-80
Other Unusual Items	26	99	2	67	-5	-4
Pretax Income	1,895	1,900	1,661	1,312	1,476	1,443
Income Tax Expense	731	754	581	540	607	607
Earnings From Continuing Operations	1,164	1,146	1,080	772	869	836
Minority Interest in Earnings	-22	-13	-41	-13	-17	-
Net Income	1,142	1,133	1,039	759	852	836
Net Income to Common	1,142	1,133	1,039	759	852	836
Net Income Growth	-9.15%	9.05%	36.89%	-10.91%	1.91%	4.37%
Shares Outstanding (Basic)	4	4	4	4	4	4
Shares Outstanding (Diluted)	4	4	4	4	4	4
Shares Change (YoY)	0.08%	0.07%	0.03%	0.02%	-0.45%	-1.03%
EPS (Basic)	303.63	301.31	276.50	202.04	226.83	221.58
EPS (Diluted)	303.63	301.31	276.50	202.04	226.83	221.58
EPS Growth	-9.23%	8.97%	36.85%	-10.93%	2.37%	5.46%
Free Cash Flow	-	202	3,975	996	813	1,352
Free Cash Flow Per Share	-	53.72	1057.83	265.13	216.45	358.34
Dividend Per Share	60.000	60.000	45.000	40.000	40.000	80.000
Dividend Growth	33.33%	33.33%	12.50%	-	-50.00%	100.00%
Gross Margin	11.73%	11.87%	11.41%	9.39%	10.76%	10.13%
Operating Margin	3.35%	3.50%	3.91%	2.76%	3.79%	3.26%
Profit Margin	2.25%	2.34%	2.60%	2.24%	2.54%	2.65%
Free Cash Flow Margin	-	0.42%	9.96%	2.94%	2.42%	4.28%
EBITDA	2,455	2,454	2,342	1,776	2,145	1,865
EBITDA Margin	4.85%	5.07%	5.87%	5.24%	6.39%	5.90%
D&A For EBITDA	756.75	762	783	841	870	835
EBIT	1,698	1,692	1,559	935	1,275	1,030
EBIT Margin	3.35%	3.50%	3.91%	2.76%	3.79%	3.26%
Effective Tax Rate	38.57%	39.68%	34.98%	41.16%	41.13%	42.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.